|
Monday, March 8, — 8:00 AM — Ballroom A
Click on the numbers in parentheses to display abstracts.
Section A - GYNECOLOGIC PATHOLOGY
Chaired by: Pincas Bitterman and Richard Zaino
| 8:00 |
Reproducibility of the Diagnosis of Atypical Endometrial Hyperplasia (AEH): A Gynecologic Oncology Group (GOG) Study
(918)
RJ Zaino, CL Trimble, SG Silverberg, J Kauderer, JP Curtin - M.S.Hershey Medical Center, Hershey, PA; Johns Hopkins Medical Institutions, Baltimore, MD; University of Maryland Medical Systems, Baltimore, MD; GOG Statistical and Data Center, Buffalo, NY; New York University Medical Center, New York, NY
|
| 8:15 |
The Histologic Features of Endometrial Hyperplasia and Well-Differentiated Carcinoma Treated by Progestins
(912)
DT Wheeler, BM Ronnett, RE Bristow, RJ Kurman - Armed Forces Institute of Pathology, Washington, DC; The Johns Hopkins Hospital, Baltimore, MD
|
| 8:30 |
Morular Metaplasia of the Endometrium Revisited: A Followup Study
(816)
CP Crum, L Lomo, MC Lin, MR Nucci, GL Mutter - Brigham and Women's Hospital, Boston, MA
|
| 8:45 |
Endometrial Gladular Dysplasia, a Newly Defined Precursor Lesion of Uterine Papillary Serous Carcinoma: A Molecular Study
(848)
SX Liang, JT Zhang, L Cheng, S Zhang, W Zheng - SUNY Stony Brook University Hospital, Stony Brook, NY; Yale University School of Medicine, New Haven, CT; Indiana University School of Medicine, Indianapolis, IN
|
| 9:00 |
Increased Expression of HIF-1a in Type II Endometrial Carcinomas
(881)
VM Pansare, MC Ionescu, R Halloush, A Hammoud, AR Munkarah, WD Lawrence, R Ali-Fehmi - Wayne State University and Karmanos Cancer Center, Detroit, MI; Brown University School of Medicine, Providence, RI
|
| 9:15 |
Prognostic Significance of Autocrine Erythropoietin Signaling in Human Endometrial Carcinoma
(789)
G Acs, X Xu, C Chu, P Acs, A Verma - University of Pennsylvania Medical Center, Philadelphia, PA; Lombardi Cancer Center, Georgetown University Hospital, Washington, DC; Uniformed Services University of the Health Sciences, Bethesda, MD
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
|
| 11:00 |
Hierarchical Clustering Analysis of the Immunostaining Profiles of Endometrial Carcinomas Identifies Prognostically Significant Subsets of Patients
(793)
A Alkushi, P Lim, A Coldman, DG Huntsman, D Miller, A Magliocco, M van de Rijn, CB Gilks - Vancouver General Hospital and University of BC, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver, BC, Canada; University of Calgary, Calgary, AB, Canada; Stanford University, Stanford, CA
|
| 11:15 |
Utility of p16 Immunoreactivity To Distinguish Endocervical from Endometrial Adenocarcinomas
(819)
LE De Las Casas, LL Talley, SJ Baker, S Korourian - University of Arkansas for Medical Sciences, Little Rock, AR
|
| 11:30 |
Chromosome 10 Rearrangements in Uterine Leiomyomata Involve the Histone Acetyltransferase MORF
(872)
SDP Moore, SR Herrick, T Ince, P Dal Cin, M Kleinman, CC Morton, BJ Quade - Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA; Massachusetts Institute of Technology, Cambridge, MA
|
| 11:45 |
Allelic Imbalances in Endometrial Stromal Neoplasms: A Model for Genetic Alterations in Tumor and Microenviromental Tissues
(871)
F Moinfar, ML Kremser, YG Man, S Lax, K Zatloukal, FA Tavassoli, H Denk - Institute of Pathology, Graz, Styria, Austria; University of Yale, New Haven, CT
|
|
|
